Clinical Trials Browser

Completed × Has results × Giant Cell Tumor of Tendon Sheath × Clear all

NCT01207492 2026-02-20

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Phase 2 Completed

17 enrolled 8 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT04526704 2024-12-30

PLX3397

Phase 4 Completed

32 enrolled 15 charts

Giant Cell Tumor of Tendon Sheath

NCT04731675 2024-06-27

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Phase 2 Completed

11 enrolled 21 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT02371369 2022-05-11

ENLIVEN

Phase 3 Completed

120 enrolled 25 charts 1 FDA

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT02471716 2021-08-31

FPA008-002

Phase 1/2 Completed

66 enrolled 20 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT04223635 2021-06-22

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Phase EARLY_PHASE1 Completed

16 enrolled 22 charts

Giant Cell Tumor of Tendon Sheath

NCT01643850 2021-01-05

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

Phase 2 Completed

36 enrolled 38 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular